Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Erwin

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2009
Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerNaomi R Schechter, William D Erwin, David J Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neckNaomi R Schechter, Richard E Wendt, David J Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaGregory A Wiseman, Bryan R Leigh, William D Erwin, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2007
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancerYoshiyuki Shioyama, Si Young Jang, H Helen Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell LymphomaJad Chahoud, Dawen Sui, William D Erwin, et al.
Journal of Applied Clinical Medical Physics|May 19, 2025
AAPM Task Group No. 249.B-Essentials and guidelines for clinical medical physics residency training programsJonathon A Nye, Joseph P Dugas, William D Erwin, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2009
Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerNaomi R Schechter, William D Erwin, David J Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neckNaomi R Schechter, Richard E Wendt, David J Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaGregory A Wiseman, Bryan R Leigh, William D Erwin, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2007
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancerYoshiyuki Shioyama, Si Young Jang, H Helen Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell LymphomaJad Chahoud, Dawen Sui, William D Erwin, et al.
Journal of Applied Clinical Medical Physics|May 19, 2025
AAPM Task Group No. 249.B-Essentials and guidelines for clinical medical physics residency training programsJonathon A Nye, Joseph P Dugas, William D Erwin, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Pageof 4